Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
705 (USA) · Dr. Muller
consented 2013-03-10
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild ELECTROCARDIOGRAM ST SEGMENT DEPRESSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-25 (study day 169.0); relationship: REMOTE
mild
assessed
Mild NAUSEA — outcome: RECOVERED/RESOLVED; onset 2013-04-08 (study day 30.0); relationship: REMOTE
mild
assessed
Mild VENTRICULAR HYPERTROPHY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-25 (study day 169.0); relationship: REMOTE
mild
assessed
Mild VOMITING — outcome: RECOVERED/RESOLVED; onset 2013-04-11 (study day 33.0); relationship: REMOTE
Data queries
No data queries.